In the BioHarmony Drug Report Database
Viekira Pak, Exviera (dasabuvir) is a small molecule pharmaceutical. Dasabuvir was first approved as Viekira Pak on 2014-12-19. It is used to treat chronic hepatitis c and hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Viekira pak’s patents are valid until 2033-10-18 (FDA).
Image (chem structure or protein)